Biosig Technologies, Inc. $BSGM Stock Position Lifted by Legacy Wealth Managment LLC ID

Key Points

• Legacy Wealth Management LLC significantly increased its stake in Biosig Technologies, purchasing an additional 2,613,335 shares, bringing its total holdings to over 6.2 million shares, making up 2.6% of its portfolio.
• Ascendiant Capital Markets has raised its price target for Biosig Technologies from $2.50 to $10.00, reflecting a strong Buy rating from analysts on Wall Street.
• Biosig Technologies reported a quarterly loss of ($0.74) per share, missing the analysts' expectations, with forecasts indicating potential earnings of -0.88 EPS for the current fiscal year.

Legacy Wealth Managment LLC ID grew its holdings in shares of Biosig Technologies, Inc. (NASDAQ:BSGM - Free Report) by 72.5% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,216,508 shares of the company's stock after purchasing an additional 2,613,335 shares during the quarter. Biosig Technologies makes up 2.6% of Legacy Wealth Managment LLC ID's investment portfolio, making the stock its 8th largest holding. Legacy Wealth Managment LLC ID owned 25.63% of Biosig Technologies worth $3,737,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. grew its holdings in Biosig Technologies by 966.3% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 266,435 shares of the company's stock valued at $160,000 after buying an additional 241,447 shares in the last quarter. Millennium Management LLC bought a new position in shares of Biosig Technologies during the fourth quarter valued at approximately $228,000. Finally, PFG Investments LLC raised its holdings in shares of Biosig Technologies by 43.5% during the first quarter. PFG Investments LLC now owns 158,286 shares of the company's stock valued at $95,000 after acquiring an additional 48,000 shares in the last quarter. Hedge funds and other institutional investors own 7.16% of the company's stock.

Biosig Technologies Trading Up 42.6%

Shares of Biosig Technologies stock traded up $1.90 during trading hours on Friday, reaching $6.35. 3,096,963 shares of the stock traded hands, compared to its average volume of 867,470. The company has a 50 day moving average price of $5.14 and a 200 day moving average price of $3.68. Biosig Technologies, Inc. has a one year low of $0.23 and a one year high of $14.11.

Biosig Technologies (NASDAQ:BSGM - Get Free Report) last released its quarterly earnings results on Friday, August 15th. The company reported ($0.74) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.04) by ($0.70). Analysts predict that Biosig Technologies, Inc. will post -0.88 EPS for the current year.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets raised their price target on Biosig Technologies from $2.50 to $10.00 and gave the company a "buy" rating in a report on Friday, June 6th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of $10.00.

Biosig Technologies Company Profile

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.